Drug intelligence / Profile preview

Bax-inhibiting peptide V5

Development stage
Unknown
Modality
Peptides
Administration
Intraperitoneal, Intrathecal
01

Overview

Bax-inhibiting peptide V5 (BIP-V5) is a cell-permeable pentapeptide (sequence: VPMLK) designed based on the Bax-binding domain of human Ku70. It acts as a cytoprotective agent by physically binding to the pro-apoptotic protein Bax (Bcl-2-associated X protein), thereby preventing its conformational activation and subsequent translocation to the outer mitochondrial membrane. By blocking mitochondrial outer membrane permeabilization (MOMP), BIP-V5 inhibits Bax-mediated apoptosis induced by various cellular stressors, including staurosporine, ultraviolet radiation, and chemotherapeutic agents. It is widely utilized as a research tool in vitro and in preclinical animal models of neurodegeneration, hypoxic-ischemic brain injury, and pulmonary fibrosis.

Other names
Bax inhibitor peptide V5Bax-inhibiting peptide, V5VPMLK
02

Targets

BAX (Apoptosis regulator BAX)

Beyond the preview

Go deeper on Bax-inhibiting peptide V5.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bax-inhibiting peptide V5.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call